NSE:ASTRAZEN (India)
Â
Shs Dematerialised
₹
8,094.5
-90.5 (-1.11%)
Jul 30
AstraZeneca Pharma India Ltd Valuation Measures
Fundamental (50)
Valuation Ratio (87)
Profitability (8)
Price (22)
Dividends (7)
Income Statement (47)
Balance Sheet (85)
Cashflow statement (66)